Related Experiment Videos

Urinary D-arabinitol/L-arabinitol levels in infants undergoing long-term antibiotic therapy

Teresa J Stradomska1, Bogumila Bobula-Milewska, Anna Bauer

  • 1Department of Laboratory Diagnostics, The Children's Memorial Health Institute, Al. Dzieci Polskich 20, 04-736 Warsaw, Poland. jstradomska@op.pl

Insights

Long-term antibiotic use increases mycosis risk. In infants, the urinary D-arabinitol/L-arabinitol (D-/L-ARA) ratio, a Candida biomarker, remained within normal limits despite antibiotic therapy, except in cases of invasive candidiasis.

Area of Science:

  • Medical Mycology
  • Pediatric Infectious Diseases
  • Clinical Chemistry

Background:

  • Long-term antibiotic therapy is a significant risk factor for fungal infections (mycosis).
  • Candida species are common causes of mycosis, particularly in vulnerable populations like infants.
  • The urinary D-arabinitol/L-arabinitol (D-/L-ARA) ratio serves as a biomarker for systemic Candida infection.

Purpose of the Study:

  • To investigate the urinary D-arabinitol/L-arabinitol (D-/L-ARA) ratio in infants receiving long-term antibiotic therapy.
  • To assess the utility of the D-/L-ARA ratio as an early indicator of invasive candidiasis in this population.

Main Methods:

  • Gas chromatography with an electron capture detector was employed to measure the urinary D-/L-ARA ratio.
  • Samples were analyzed from 51 infants undergoing prolonged antibiotic treatment.
  • Ratios were compared to those of healthy controls and established upper-normal limits.

Main Results:

  • A statistically significant elevation in the D-/L-ARA ratio was observed in 47 out of 51 infants compared to healthy controls (P<0.0003).
  • Despite the elevation, the ratios in most infants remained within the upper-normal range (<3.6).
  • Four infants with suspected invasive candidiasis exhibited above-normal D-/L-ARA ratios, which normalized after fluconazole treatment.

Conclusions:

  • Long-term antibiotic therapy in infants does not typically lead to significantly elevated urinary D-/L-ARA ratios beyond normal limits.
  • The urinary D-/L-ARA ratio may be a useful biomarker for detecting invasive candidiasis in infants, as indicated by normalization after antifungal treatment.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care01:30

Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care

A healthcare provider can diagnose a urinary tract infection (UTI) through several methods:Medical History and Symptoms: The provider will take a detailed medical history and ask about symptoms such as frequent urination, burning sensation during urination, and lower abdominal pain.Urinalysis: A clean-catch urine sample is collected in a sterile container and tested for the presence of bacteria, white blood cells (leukocytes), nitrites, blood, and protein. The presence of leukocytes and...
Urine Studies II: Urine Culture and Sensitivity Test01:26

Urine Studies II: Urine Culture and Sensitivity Test

A urine culture and sensitivity test is a diagnostic procedure used to identify urinary tract bacterial infections and determine the most effective antibiotics for treatment. This test is generally preferred when a patient shows manifestations of a urinary tract infection, such as frequent or painful urination, cloudy or foul-smelling urine, or lower abdominal pain.Purpose of the TestThe primary goals of a urine culture and sensitivity test are to:Determine the specific bacteria causing the...
Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations01:15

Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations

Gentamicin, an aminoglycoside antibiotic, is commonly administered via intermittent intravenous infusion to treat severe infections. An intermittent one-hour infusion of gentamicin, administered at eight-hour intervals, allows for precise control of plasma drug concentrations, minimizing toxicity while ensuring therapeutic efficacy. Pharmacokinetic principles govern the dynamics of plasma concentrations and can be mathematically described using specific equations.The plasma drug concentration...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Urine Studies I: Urinalysis01:29

Urine Studies I: Urinalysis

Urinalysis is a widely used diagnostic test that analyzes urine's physical, chemical, and microscopic characteristics. Healthcare providers use it to detect and monitor various health conditions, including renal disease, urinary tract infections (UTIs), diabetes, and metabolic or systemic disorders.Components of UrinalysisUrinalysis consists of three primary components: physical, chemical, and microscopic examination. Each provides unique insights into the urine sample and, by extension, the...